Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination wound dressing formulation that incorporates scarlet red (Sudan IV), microbial nanocellulose, hyaluronan, and thrombin. This advanced biomaterial system likely combines the antimicrobial properties of nanocellulose, the controlled release capabilities of hyaluronan, the wound healing promotion of scarlet red, and the hemostatic effects of thrombin. The formulation is designed for enhanced wound healing, particularly for complex or chronic wounds requiring multiple therapeutic actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on scarlet red + microbial nanocellulose + hyaluronan + thrombin.